Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects
Clinical trial NCT01879020 · COMPLETED
Trial details
- NCT number
- NCT01879020
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-06-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.